{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:53:35Z","timestamp":1771876415250,"version":"3.50.1"},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T00:00:00Z","timestamp":1153180800000},"content-version":"vor","delay-in-days":5908,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[1990,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Using a sandwich enzyme\u2010linked immunosorbent assay (ELISA) we were able to detect a soluble form of the CD30 antigen (CD30s) in the supernatant of cell lines expressing membrane\u2010bound CD30 and in T and B cells after transformation with human T\u2010cell leukemia virus (HTLV\u20101) and Epstein\u2010Barr\u2010Virus (EBV). While CD30s was not found in 250 healthy controls, it was detected in the sera of patients with Hodgkin's disease (23\/100), anaplastic large\u2010cell (6\/9), angioimmunoblastic (2\/2) and one unclassified high\u2010grade non\u2010Hodgkin's lymphoma (NHL), as well as in 18\/20 patients with acute adult T\u2010cell leukemia (ATL, HTLV\u20101\u2010positive). It was absent in a large number of patients with other high\u2010grade NHL, all low\u2010grade NHLs, acute or chronic leukemias and solid tumors. The only non\u2010malignant disease with detectable levels of CD30s was infectious mononucleosis (9\/10). The membrane\u2010bound form of CD30 has a molecular weight of 120 kDa. Western blot analysis revealed that CD30s in the serum of patients has a molecular weight of 88 kDa, identical to the antigen released by cell lines <jats:italic>in vitro<\/jats:italic>. CD30s disappeared in all originally positive cases after successful treatment and reappeared in relapsing patients. Thus, CD30s may be useful as a specific marker for disease activity of certain types of lymphoma and ATL.<\/jats:p>","DOI":"10.1002\/ijc.2910450515","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T21:55:30Z","timestamp":1171922130000},"page":"869-874","source":"Crossref","is-referenced-by-count":33,"title":["Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T\u2010cell leukemia and infectious mononucleosis"],"prefix":"10.1002","volume":"45","author":[{"given":"M.","family":"Pfreundschuh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Berenbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Schmits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tschiersch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,18]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-83781-4_11"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.4.596"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830190125"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/227680a0"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","unstructured":"Lemke H. Hansen H. Bredfedt G. Havsteen B.andK\u00f6nnecke I. The Hodgkin\u2010associated Ki\u20101 antigen exists in an intracellular and a membrane\u2010bound form. Proc. 7th Int. Congress Immunol. Berlin 1989 Abstract W101\u201320 (1989).","DOI":"10.1515\/bchm3.1989.370.1.409"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00320290"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-4-274"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1159\/000216681"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000216482"},{"key":"e_1_2_1_11_1","first-page":"217","article-title":"Hodgkin\u2010and\u2010Reed\u2010Stemberg\u2010cell\u2010associated monoclonal antibodies HRS\u20101 and HRS\u20102 react with activated cells of lymphoid and monocytoid origin","volume":"8","author":"Pfreundschuh M.","year":"1988","journal-title":"Anticancer Res."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1987.83"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/299065a0"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin's\u2010disease\u2010associated antigen Ki\u20101 in reactive and neoplastic lymphoid tissue: evidence that Reed\u2010Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein H.","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(87)90157-8"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(84)90001-2"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(85)90358-X"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.8.1262"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198902233200806"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.2910450515","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.2910450515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T18:06:36Z","timestamp":1697997996000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.2910450515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5,15]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,5,15]]}},"alternative-id":["10.1002\/ijc.2910450515"],"URL":"https:\/\/doi.org\/10.1002\/ijc.2910450515","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,5,15]]}}}